S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CMPX Compass Therapeutics Inc

2.65

-0.45 (-14.52%)

Jan 24 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Compass Therapeutics Charts.

Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Compass Therapeutics Charts.

Compass Therapeutics Inc News

Another Day, Another Biotech Stealing The Show
Wednesday 8 January 2025 (2 weeks ago) • AllPennyStocks.com

Form 8-K - Current report
Wednesday 8 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate
Wednesday 8 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 10 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 10 December 2024 (1 month ago) • Edgar (US Regulatory)

Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer
Tuesday 10 December 2024 (1 month ago) • GlobeNewswire Inc.

Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Monday 2 December 2024 (2 months ago) • GlobeNewswire Inc.

Compass Therapeutics to Participate in Upcoming Investor Events
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Friday 8 November 2024 (3 months ago) • GlobeNewswire Inc.

More Compass Therapeutics Inc News Articles

SG Issuer Societe Generale

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions